Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report

Purpose. To present the case of a 27-year-old male patient with stage IV proliferative sickle cell retinopathy, treated with one intravitreal injection of ranibizumab, showing regression of the neovascularization and no recurrence at the 9-month follow-up. Methods. A 27-year-old male patient present...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitropoulos, Panagiotis G., Chatziralli, Irini P., Parikakis, Efstratios A., Peponis, Vasileios G., Amariotakis, Georgios A., Moschos, Marilita M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258923/
https://www.ncbi.nlm.nih.gov/pubmed/25506450
http://dx.doi.org/10.1155/2014/682583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258923/
https://www.ncbi.nlm.nih.gov/pubmed/25506450
http://dx.doi.org/10.1155/2014/682583

Ejemplares similares